Table of Contents 1 Study Coverage 1.1 Rivaroxaban Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Rivaroxaban Market Size Growth Rate by Product 1.4.2 2.5 mg 1.4.3 10 mg 1.4.4 15 mg 1.4.5 20 mg 1.5 Market by End User 1.5.1 Global Rivaroxaban Market Size Growth Rate by End User 1.5.2 Acute Coronary Syndrome (ACS) 1.5.3 Venous Thromboembolism (VTE) 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Rivaroxaban Market Size 2.1.1 Global Rivaroxaban Revenue 2014-2025 2.1.2 Global Rivaroxaban Sales 2014-2025 2.2 Rivaroxaban Growth Rate by Regions 2.2.1 Global Rivaroxaban Sales by Regions 2.2.2 Global Rivaroxaban Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Rivaroxaban Sales by Manufacturers 3.1.1 Rivaroxaban Sales by Manufacturers 3.1.2 Rivaroxaban Sales Market Share by Manufacturers 3.1.3 Global Rivaroxaban Market Concentration Ratio (CR5 and HHI) 3.2 Rivaroxaban Revenue by Manufacturers 3.2.1 Rivaroxaban Revenue by Manufacturers (2014-2019) 3.2.2 Rivaroxaban Revenue Share by Manufacturers (2014-2019) 3.3 Rivaroxaban Price by Manufacturers 3.4 Rivaroxaban Manufacturing Base Distribution, Product Types 3.4.1 Rivaroxaban Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Rivaroxaban Product Type 3.4.3 Date of International Manufacturers Enter into Rivaroxaban Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Rivaroxaban Sales by Product 4.2 Global Rivaroxaban Revenue by Product 4.3 Rivaroxaban Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Rivaroxaban Breakdown Data by End User 6 North America 6.1 North America Rivaroxaban by Countries 6.1.1 North America Rivaroxaban Sales by Countries 6.1.2 North America Rivaroxaban Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Rivaroxaban by Product 6.3 North America Rivaroxaban by End User 7 Europe 7.1 Europe Rivaroxaban by Countries 7.1.1 Europe Rivaroxaban Sales by Countries 7.1.2 Europe Rivaroxaban Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Rivaroxaban by Product 7.3 Europe Rivaroxaban by End User 8 Asia Pacific 8.1 Asia Pacific Rivaroxaban by Countries 8.1.1 Asia Pacific Rivaroxaban Sales by Countries 8.1.2 Asia Pacific Rivaroxaban Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Rivaroxaban by Product 8.3 Asia Pacific Rivaroxaban by End User 9 Central & South America 9.1 Central & South America Rivaroxaban by Countries 9.1.1 Central & South America Rivaroxaban Sales by Countries 9.1.2 Central & South America Rivaroxaban Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Rivaroxaban by Product 9.3 Central & South America Rivaroxaban by End User 10 Middle East and Africa 10.1 Middle East and Africa Rivaroxaban by Countries 10.1.1 Middle East and Africa Rivaroxaban Sales by Countries 10.1.2 Middle East and Africa Rivaroxaban Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Rivaroxaban by Product 10.3 Middle East and Africa Rivaroxaban by End User 11 Company Profiles 11.1 Bayer 11.1.1 Bayer Company Details 11.1.2 Company Business Overview 11.1.3 Bayer Rivaroxaban Sales, Revenue and Gross Margin (2014-2019) 11.1.4 Bayer Rivaroxaban Products Offered 11.1.5 Bayer Recent Development 11.2 J&J 11.2.1 J&J Company Details 11.2.2 Company Business Overview 11.2.3 J&J Rivaroxaban Sales, Revenue and Gross Margin (2014-2019) 11.2.4 J&J Rivaroxaban Products Offered 11.2.5 J&J Recent Development 12 Future Forecast 12.1 Rivaroxaban Market Forecast by Regions 12.1.1 Global Rivaroxaban Sales Forecast by Regions 2019-2025 12.1.2 Global Rivaroxaban Revenue Forecast by Regions 2019-2025 12.2 Rivaroxaban Market Forecast by Product 12.2.1 Global Rivaroxaban Sales Forecast by Product 2019-2025 12.2.2 Global Rivaroxaban Revenue Forecast by Product 2019-2025 12.3 Rivaroxaban Market Forecast by End User 12.4 North America Rivaroxaban Forecast 12.5 Europe Rivaroxaban Forecast 12.6 Asia Pacific Rivaroxaban Forecast 12.7 Central & South America Rivaroxaban Forecast 12.8 Middle East and Africa Rivaroxaban Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Rivaroxaban Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure Rivaroxaban Product Picture Table Rivaroxaban Market Segments Table Key Manufacturers Rivaroxaban Covered Table Global Rivaroxaban Market Size Growth Rate by Product 2019-2025 (M Units) & (Million US$) Figure Global Rivaroxaban Sales Market Share by Product 2014-2025 Figure 2.5 mg Product Picture Table Major Manufacturers of 2.5 mg Figure 10 mg Product Picture Table Major Manufacturers of 10 mg Figure 15 mg Product Picture Table Major Manufacturers of 15 mg Figure 20 mg Product Picture Table Major Manufacturers of 20 mg Table Global Rivaroxaban Market Size Growth Rate by End User 2019-2025 (M Units) Figure Acute Coronary Syndrome (ACS) Figure Venous Thromboembolism (VTE) Figure Rivaroxaban Report Years Considered Figure Global Rivaroxaban Market Size 2014-2025 (Million US$) Figure Global Rivaroxaban Sales 2014-2025 (M Units) Table Global Rivaroxaban Market Size by Regions 2014-2019 (M Units) & (Million US$) Table Global Rivaroxaban Sales by Regions 2014-2019 (M Units) Table Global Rivaroxaban Sales Market Share by Regions 2014-2019 Figure Global Rivaroxaban Sales Market Share by Regions 2014-2019 Figure 2018 Global Rivaroxaban Sales Market Share by Regions Table Global Rivaroxaban Revenue by Regions 2014-2019 (Million US$) Table Global Rivaroxaban Revenue Market Share by Regions 2014-2019 Figure Global Rivaroxaban Revenue Market Share by Regions 2014-2019 Figure 2018 Global Rivaroxaban Revenue Market Share by Regions Table Global Rivaroxaban Sales by Manufacturers (2014-2019) (M Units) Table Global Rivaroxaban Sales Share by Manufacturers (2014-2019) Figure Global Rivaroxaban Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Rivaroxaban Revenue by Manufacturers (2014-2019) (Million USD) Table Rivaroxaban Revenue Share by Manufacturers (2014-2019) Figure Rivaroxaban Value Share by Manufacturers in 2018 Table Key Manufacturers Rivaroxaban Price (2014-2019) (USD/Unit) Table Rivaroxaban Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Rivaroxaban Product Type Table Date of International Manufacturers Enter into Rivaroxaban Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Rivaroxaban Sales by Product (2014-2019) (M Units) Table Global Rivaroxaban Sales Share by Product (2014-2019) Figure Global Rivaroxaban Sales Market Share by Product (2014-2019) Figure Global Rivaroxaban Sales Market Share by Product in 2018 Table Global Rivaroxaban Revenue by Product (2014-2019) (Million US$) Table Global Rivaroxaban Revenue Share by Product (2014-2019) Figure Global Rivaroxaban Revenue Market Share by Product (2014-2019) Figure Global Rivaroxaban Revenue Market Share by Product in 2018 Table Rivaroxaban Price by Product 2014-2019 (USD/Unit) Table Global Rivaroxaban Sales by End User (2014-2019) (M Units) Table Global Rivaroxaban Sales Share by End User (2014-2019) Figure Global Sales Rivaroxaban Market Share by End User (2014-2019) Figure Global Sales Rivaroxaban Market Share by End User in 2018 Figure North America Rivaroxaban Sales Growth Rate 2014-2019 (M Units) Figure North America Rivaroxaban Revenue Growth Rate 2014-2019 (Million US$) Table North America Rivaroxaban Sales by Countries (2014-2019) (M Units) Table North America Rivaroxaban Sales Market Share by Countries (2014-2019) Figure 2018 North America Rivaroxaban Sales Market Share by Countries Table North America Rivaroxaban Revenue by Countries (2014-2019) (Million US$) Table North America Rivaroxaban Revenue Market Share by Countries (2014-2019) Figure 2018 North America Rivaroxaban Revenue Market Share by Countries Figure United States Rivaroxaban Sales Growth Rate (2014-2019) (M Units) Figure United States Rivaroxaban Revenue Growth Rate (2014-2019) (M Units) Figure Canada Rivaroxaban Sales Growth Rate (2014-2019) (M Units) Figure Canada Rivaroxaban Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Rivaroxaban Sales Growth Rate (2014-2019) (M Units) Figure Mexico Rivaroxaban Revenue Growth Rate (2014-2019) (Million US$) Table North America Rivaroxaban Sales by Product (2014-2019) (M Units) Table North America Rivaroxaban Sales Market Share by Product (2014-2019) Figure 2018 North America Rivaroxaban Market Share by Product Table North America Rivaroxaban Sales by End User (2014-2019) (M Units) Table North America Rivaroxaban Sales Market Share by End User (2014-2019) Figure 2018 North America Rivaroxaban Market Share by End User Figure Europe Rivaroxaban Sales Growth Rate 2014-2019 (M Units) Figure Europe Rivaroxaban Revenue Growth Rate 2014-2019 (Million US$) Table Europe Rivaroxaban Sales by Countries (2014-2019) (M Units) Table Europe Rivaroxaban Sales Market Share by Countries (2014-2019) Figure 2018 Europe Rivaroxaban Sales Market Share by Countries Table Europe Rivaroxaban Revenue by Countries (2014-2019) (Million US$) Table Europe Rivaroxaban Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Rivaroxaban Revenue Market Share by Countries Figure Germany Rivaroxaban Sales Growth Rate (2014-2019) (M Units) Figure Germany Rivaroxaban Revenue Growth Rate (2014-2019) (Million US$) Figure France Rivaroxaban Sales Growth Rate (2014-2019) (M Units) Figure France Rivaroxaban Revenue Growth Rate (2014-2019) (Million US$) Figure UK Rivaroxaban Sales Growth Rate (2014-2019) (M Units) Figure UK Rivaroxaban Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Rivaroxaban Sales Growth Rate (2014-2019) (M Units) Figure Italy Rivaroxaban Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Rivaroxaban Sales Growth Rate (2014-2019) (M Units) Figure Russia Rivaroxaban Revenue Growth Rate (2014-2019) (Million US$) Table Europe Rivaroxaban Sales by Product (2014-2019) (M Units) Table Europe Rivaroxaban Sales Market Share by Product (2014-2019) Figure 2018 Europe Rivaroxaban Market Share by Product Table Europe Rivaroxaban Sales by End User (2014-2019) (M Units) Table Europe Rivaroxaban Sales Market Share by End User (2014-2019) Figure 2018 Europe Rivaroxaban Market Share by End User Figure Asia Pacific Rivaroxaban Sales Growth Rate 2014-2019 (M Units) Figure Asia Pacific Rivaroxaban Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Rivaroxaban Sales by Countries (2014-2019) (M Units) Table Asia Pacific Rivaroxaban Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Rivaroxaban Sales Market Share by Countries Table Asia Pacific Rivaroxaban Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Rivaroxaban Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Rivaroxaban Revenue Market Share by Countries Figure China Rivaroxaban Sales Growth Rate (2014-2019) (M Units) Figure China Rivaroxaban Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Rivaroxaban Sales Growth Rate (2014-2019) (M Units) Figure Japan Rivaroxaban Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Rivaroxaban Sales Growth Rate (2014-2019) (M Units) Figure Korea Rivaroxaban Revenue Growth Rate (2014-2019) (Million US$) Figure India Rivaroxaban Sales Growth Rate (2014-2019) (M Units) Figure India Rivaroxaban Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Rivaroxaban Sales Growth Rate (2014-2019) (M Units) Figure Australia Rivaroxaban Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Rivaroxaban Sales Growth Rate (2014-2019) (M Units) Figure Indonesia Rivaroxaban Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Rivaroxaban Sales Growth Rate (2014-2019) (M Units) Figure Malaysia Rivaroxaban Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Rivaroxaban Sales Growth Rate (2014-2019) (M Units) Figure Philippines Rivaroxaban Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Rivaroxaban Sales Growth Rate (2014-2019) (M Units) Figure Thailand Rivaroxaban Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Rivaroxaban Sales Growth Rate (2014-2019) (M Units) Figure Vietnam Rivaroxaban Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Rivaroxaban Sales Growth Rate (2014-2019) (M Units) Figure Singapore Rivaroxaban Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Rivaroxaban Sales by Product (2014-2019) (M Units) Table Asia Pacific Rivaroxaban Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Rivaroxaban Market Share by Product Table Asia Pacific Rivaroxaban Sales by End User (2014-2019) (M Units) Table Asia Pacific Rivaroxaban Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Rivaroxaban Market Share by End User Figure Central & South America Rivaroxaban Sales Growth Rate 2014-2019 (M Units) Figure Central & South America Rivaroxaban Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Rivaroxaban Sales by Countries (2014-2019) (M Units) Table Central & South America Rivaroxaban Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Rivaroxaban Sales Market Share by Countries Table Central & South America Rivaroxaban Revenue by Countries (2014-2019) (Million US$) Table Central & South America Rivaroxaban Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Rivaroxaban Revenue Market Share by Countries Figure Brazil Rivaroxaban Sales Growth Rate (2014-2019) (M Units) Figure Brazil Rivaroxaban Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Rivaroxaban Sales Growth Rate (2014-2019) (M Units) Figure Argentina Rivaroxaban Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Rivaroxaban Sales by Product (2014-2019) (M Units) Table Central & South America Rivaroxaban Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Rivaroxaban Market Share by Product Table Central & South America Rivaroxaban Sales by End User (2014-2019) (M Units) Table Central & South America Rivaroxaban Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Rivaroxaban Market Share by End User Figure Middle East and Africa Rivaroxaban Sales Growth Rate 2014-2019 (M Units) Figure Middle East and Africa Rivaroxaban Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Rivaroxaban Sales by Countries (2014-2019) (M Units) Table Middle East and Africa Rivaroxaban Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Rivaroxaban Sales Market Share by Countries Table Middle East and Africa Rivaroxaban Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Rivaroxaban Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Rivaroxaban Revenue Market Share by Countries Figure GCC Countries Rivaroxaban Sales Growth Rate (2014-2019) (M Units) Figure GCC Countries Rivaroxaban Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Rivaroxaban Sales Growth Rate (2014-2019) (M Units) Figure Turkey Rivaroxaban Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Rivaroxaban Sales Growth Rate (2014-2019) (M Units) Figure Egypt Rivaroxaban Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Rivaroxaban Sales Growth Rate (2014-2019) (M Units) Figure South Africa Rivaroxaban Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Rivaroxaban Sales by Product (2014-2019) (M Units) Table Middle East and Africa Rivaroxaban Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Rivaroxaban Market Share by Product Table Middle East and Africa Rivaroxaban Sales by End User (2014-2019) (M Units) Table Middle East and Africa Rivaroxaban Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Rivaroxaban Market Share by End User Table Bayer Company Details Table Bayer Rivaroxaban Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Bayer Recent Development Table J&J Company Details Table J&J Rivaroxaban Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table J&J Recent Development Table Global Rivaroxaban Sales Forecast by Regions 2019-2025 (M Units) Table Global Rivaroxaban Sales Market Share Forecast by Regions 2019-2025 Table Global Rivaroxaban Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Rivaroxaban Revenue Market Share Forecast by Regions 2019-2025 Table Global Rivaroxaban Sales Forecast by Product 2019-2025 (M Units) Table Global Rivaroxaban Sales Market Share Forecast by Product 2019-2025 Table Global Rivaroxaban Revenue Forecast by Product 2019-2025 (Million US$) Table Global Rivaroxaban Revenue Market Share Forecast by Product 2019-2025 Table Global Rivaroxaban Sales Forecast by End User 2019-2025 (M Units) Table Global Rivaroxaban Sales Market Share Forecast by End User 2019-2025 Figure North America Rivaroxaban Sales Growth Rate Forecast (2019-2025) (M Units) Figure North America Rivaroxaban Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Rivaroxaban Sales Growth Rate Forecast (2019-2025) (M Units) Figure Europe Rivaroxaban Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Rivaroxaban Sales Growth Rate Forecast (2019-2025) (M Units) Figure Asia Pacific Rivaroxaban Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Rivaroxaban Sales Growth Rate Forecast (2019-2025) (M Units) Figure Central & South America Rivaroxaban Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Rivaroxaban Sales Growth Rate Forecast (2019-2025) (M Units) Figure Middle East and Africa Rivaroxaban Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Rivaroxaban Value Chain Table Rivaroxaban Customers List Table Rivaroxaban Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Bayer J&J